273 related articles for article (PubMed ID: 33789425)
21. Blockade of KCa3.1 Attenuates Left Ventricular Remodeling after Experimental Myocardial Infarction.
Ju CH; Wang XP; Gao CY; Zhang SX; Ma XH; Liu C
Cell Physiol Biochem; 2015; 36(4):1305-15. PubMed ID: 26160442
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-150 Inhibits the Activation of Cardiac Fibroblasts by Regulating c-Myb.
Deng P; Chen L; Liu Z; Ye P; Wang S; Wu J; Yao Y; Sun Y; Huang X; Ren L; Zhang A; Wang K; Wu C; Yue Z; Xu X; Chen M
Cell Physiol Biochem; 2016; 38(6):2103-22. PubMed ID: 27184887
[TBL] [Abstract][Full Text] [Related]
23. CD90
Chang Y; Li C; Jia Y; Chen P; Guo Y; Li A; Guo Z
Int J Biochem Cell Biol; 2018 Mar; 96():20-28. PubMed ID: 29339198
[TBL] [Abstract][Full Text] [Related]
24. SPRR1A is a key downstream effector of MiR-150 during both maladaptive cardiac remodeling in mice and human cardiac fibroblast activation.
Kawaguchi S; Moukette B; Sepúlveda MN; Hayasaka T; Aonuma T; Haskell AK; Mah J; Liangpunsakul S; Tang Y; Conway SJ; Kim IM
Cell Death Dis; 2023 Jul; 14(7):446. PubMed ID: 37468478
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
Travers JG; Kamal FA; Valiente-Alandi I; Nieman ML; Sargent MA; Lorenz JN; Molkentin JD; Blaxall BC
J Am Coll Cardiol; 2017 Aug; 70(8):958-971. PubMed ID: 28818206
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction.
Tillmanns J; Hoffmann D; Habbaba Y; Schmitto JD; Sedding D; Fraccarollo D; Galuppo P; Bauersachs J
J Mol Cell Cardiol; 2015 Oct; 87():194-203. PubMed ID: 26319660
[TBL] [Abstract][Full Text] [Related]
27. Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin.
Trueblood NA; Xie Z; Communal C; Sam F; Ngoy S; Liaw L; Jenkins AW; Wang J; Sawyer DB; Bing OH; Apstein CS; Colucci WS; Singh K
Circ Res; 2001 May; 88(10):1080-7. PubMed ID: 11375279
[TBL] [Abstract][Full Text] [Related]
28. Novel technique for the simultaneous isolation of cardiac fibroblasts and epicardial stromal cells from the infarcted murine heart.
Owenier C; Hesse J; Alter C; Ding Z; Marzoq A; Petzsch P; Köhrer K; Schrader J
Cardiovasc Res; 2020 Apr; 116(5):1047-1058. PubMed ID: 31504244
[TBL] [Abstract][Full Text] [Related]
29. PCSK9 Inhibition Regulates Infarction-Induced Cardiac Myofibroblast Transdifferentiation via Notch1 Signaling.
Wu C; Lin D; Ji J; Jiang Y; Jiang F; Wang Y
Cell Biochem Biophys; 2023 Jun; 81(2):359-369. PubMed ID: 37081375
[TBL] [Abstract][Full Text] [Related]
30. Fibroblast Primary Cilia Are Required for Cardiac Fibrosis.
Villalobos E; Criollo A; Schiattarella GG; Altamirano F; French KM; May HI; Jiang N; Nguyen NUN; Romero D; Roa JC; García L; Diaz-Araya G; Morselli E; Ferdous A; Conway SJ; Sadek HA; Gillette TG; Lavandero S; Hill JA
Circulation; 2019 May; 139(20):2342-2357. PubMed ID: 30818997
[TBL] [Abstract][Full Text] [Related]
31. Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction.
de Kleijn DPV; Chong SY; Wang X; Yatim SMJM; Fairhurst AM; Vernooij F; Zharkova O; Chan MY; Foo RSY; Timmers L; Lam CSP; Wang JW
Cardiovasc Res; 2019 Oct; 115(12):1791-1803. PubMed ID: 30830156
[TBL] [Abstract][Full Text] [Related]
32. Proteomic basis of modulation of postischemic fibrosis by MSC exosomes.
Kore RA; Wang X; Henson JC; Ding Z; Jamshidi-Parsian A; Mehta JL
Am J Physiol Regul Integr Comp Physiol; 2021 Nov; 321(5):R639-R654. PubMed ID: 34431382
[TBL] [Abstract][Full Text] [Related]
33. Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction.
Venugopal H; Hanna A; Humeres C; Frangogiannis NG
Cells; 2022 Apr; 11(9):. PubMed ID: 35563692
[TBL] [Abstract][Full Text] [Related]
34. Defining the timeline of periostin upregulation in cardiac fibrosis following acute myocardial infarction in mice.
Gil H; Goldshtein M; Etzion S; Elyagon S; Hadad U; Etzion Y; Cohen S
Sci Rep; 2022 Dec; 12(1):21863. PubMed ID: 36529756
[TBL] [Abstract][Full Text] [Related]
35. NEIL3-Dependent Regulation of Cardiac Fibroblast Proliferation Prevents Myocardial Rupture.
Olsen MB; Hildrestrand GA; Scheffler K; Vinge LE; Alfsnes K; Palibrk V; Wang J; Neurauter CG; Luna L; Johansen J; Øgaard JDS; Ohm IK; Slupphaug G; Kuśnierczyk A; Fiane AE; Brorson SH; Zhang L; Gullestad L; Louch WE; Iversen PO; Østlie I; Klungland A; Christensen G; Sjaastad I; Sætrom P; Yndestad A; Aukrust P; Bjørås M; Finsen AV
Cell Rep; 2017 Jan; 18(1):82-92. PubMed ID: 28052262
[TBL] [Abstract][Full Text] [Related]
36. Haplodeficiency of activin receptor-like kinase 4 alleviates myocardial infarction-induced cardiac fibrosis and preserves cardiac function.
Chen YH; Wang Q; Li CY; Hou JW; Chen XM; Zhou Q; Chen J; Wang YP; Li YG
J Mol Cell Cardiol; 2017 Apr; 105():1-11. PubMed ID: 28214509
[TBL] [Abstract][Full Text] [Related]
37. GRK5-mediated inflammation and fibrosis exert cardioprotective effects during the acute phase of myocardial infarction.
Nagasaka A; Terawaki T; Noda M; Takashima M; Fujino M; Yamauchi Y; Arawaka S; Kato T; Nakaya M
FEBS Open Bio; 2023 Feb; 13(2):380-391. PubMed ID: 36633120
[TBL] [Abstract][Full Text] [Related]
38. Toll-like receptor 4 contributes to a myofibroblast phenotype in cardiac fibroblasts and is associated with autophagy after myocardial infarction in a mouse model.
Yang R; Song Z; Wu S; Wei Z; Xu Y; Shen X
Atherosclerosis; 2018 Dec; 279():23-31. PubMed ID: 30399463
[TBL] [Abstract][Full Text] [Related]
39. C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation.
Lei H; Wu D; Wang JY; Li L; Zhang CL; Feng H; Fu FY; Wu LL
Basic Res Cardiol; 2015; 110(4):35. PubMed ID: 25962701
[TBL] [Abstract][Full Text] [Related]
40. CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response.
Huebener P; Abou-Khamis T; Zymek P; Bujak M; Ying X; Chatila K; Haudek S; Thakker G; Frangogiannis NG
J Immunol; 2008 Feb; 180(4):2625-33. PubMed ID: 18250474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
